Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 275-702-5 | CAS number: 71617-10-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May - July 1975
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- The study appears scientificially sound and is well documented, but no information on guidelines followed and GLP status are available.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 975
- Report date:
- 1975
Materials and methods
- Principles of method if other than guideline:
- The study was aimed at obtaining knowledge on the signs of poisoning, the lowest toxic dose, and the lethal dose (LD50) of isopentyl p-methoxycinnamate with single peroral administration to rats.
The experimental animals consisted of male and female Sprague-Dawley rats (an outbred strain from the firm S. IVANOVAS GmbH & Co., Med. Experimental Animal Breeds KG (Kißlegg/ Allgäu, Germany). The animals, with weights between 100 and 105 g, were aged 38 (males) and 42 (females) days.
The animals were housed singly in MAKROLON (type II) cages at a room temperature of 24±0.5°C (maximum limit), and a relative humidity of 60±3 % (maximum limit).
The test substance was available in the original liquid form and given undiluted in a signle administration by gavage. The feed (ALTROMIN 1323 from the ALTROMIN GmbH, Lage/Lippe, Germany) was removed 15 - 16 h prior to application, whereas tap water remained available ad libitum.
There was a recovery period of four weeks, during which time the behavior, feed intake, and body-weight development were monitored. At the end of this period, all animals were necropsied and examined macroscopically. - GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Isopentyl p-methoxycinnamate
- EC Number:
- 275-702-5
- EC Name:
- Isopentyl p-methoxycinnamate
- Cas Number:
- 71617-10-2
- Molecular formula:
- C15H20O3
- IUPAC Name:
- isopentyl p-methoxycinnamate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The experimental animals consisted of male and female Sprague-Dawley rats (an outbred strain from the firm S. IVANOVAS GmbH & Co., Med. Experimental Animal Breeds KG (Kißlegg/Allgäu, Germany). The animals, with weights between 100 and 105 g, were aged 38 (males) and 42 (females) days.
The animals were housed singly in MAKROLON (type II) cages at a room temperature of 24±0.5°C (maximal limit), and a relative humidity of 60±3 % (maximal limit).
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- The test substance was available in the original liquid form and given undiluted in a single administration by gavage. The feed (ALTROMIN 1323 from the ALTROMIN GmbH, Postfach 285, 4937 Lage/ Lippe) was removed 15 - 16 hours prior to application, whereas tap water remained available ad libitum.
- Doses:
- Dose intervals were based on a factor of 1.26.
Tested doses: 3180, 4000, 5040, 6350, 7900, 9600, 9900 and 10000 mg/kg bw. - No. of animals per sex per dose:
- Ten male and ten female animals were used per dose.
- Control animals:
- not specified
- Details on study design:
- There was a recovery period of four weeks, during which time the behaviour, feed intake, and body weight development were monitored. At the end of this period, all animals were necropsied and examined macroscopically.
- Statistics:
- no data
Results and discussion
- Preliminary study:
- none
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 9 900 mg/kg bw
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- ca. 9 600 mg/kg bw
- Mortality:
- LD50 (7 days) : Sedation, ataxia, (4000 mg/kg p.o.), slow shallow breathing, reduced feed intake (5040 mg/kg p.o.), increased lacrimination, prone position, cataleptonic conditions, general reflexes are difficult to trigger, coma (10000 mg/kg p.o.). Death occured 10-24 h after application in coma.
- Clinical signs:
- other: see section "Any other information including tables" below
- Gross pathology:
- Necropsy: animals found dead showed pale parenchymal organs.
- Other findings:
- see below
Any other information on results incl. tables
3180 mg/kg p.o.: No indication od toxic reactions. Necropsy: no specific pathological findings
4000 mg/kg p.o.: About 50 min after application, slight sedation and ataxia of all animals for 1 - 3 h. Necropsy: no specific pathological findings
5040 mg/kg p.o.: 30 - 60 min. after application, slight sedation and ataxia of all animals for 2 - 6 h; accompanied by slow and shallow breathing. Necropsy: no specific pathological findings.
6350 mg/kg p.o: About 30 min. after application, medium sedation and ataxia of all animals for 24 - 36 h. Slow, shallow breathing for about 4 - 6 h. Necropsy: no specific pathological findings
7900 mg/kg p.o. : About 30 min. after application, medium sedation and ataxia of all animals for 24 - 48 h. Slow, shallow breathing for about 4 - 6 h. Necropsy: no secific pathological findings.
10000 mg/kg p.o. : 20 - 30 min. after application, all animals revealed severe sedation, ataxia and increased lacrimation; phases of prone position and cataleptonic conditions. Slow and shallow breathing for about 6 h, general reflexes are difficult to trigger. In 6 males and 8 females, sedation deepened to coma 4 - 40 h after application. Death occured in coma, 12 - 24 h after application. Necropsy: pale parenchymal organs in animals found dead. Surviving animals showed no specific pathological findings.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- Migrated information
- Conclusions:
- Isopentyl p-methoxycinnamate was found to posses a low degree of toxicity, with the LD50 value being 9,900 mg/kg bw and 9,600 mg/kg bw, for male and female rats, respectively.
- Executive summary:
The acute toxicity of isopentyl p-methoxycinnamate upon oral administration to male and female rats. The test item was found to posses a low degree of toxicity, with the LD50 value being 9,900 mg/kg bw and 9,600 mg/kg bw, for male and female rats, respectively.
At the highest dose level of 10000 mg/kg bw, all animals revealed severe sedation, ataxia and increased lacrimation as well as phases of prone position and cataleptonic conditions at 20 -30 min after application. Slow and shallow breathing was observed for about 6 hours, general reflexes were difficult to trigger. In 6 males and 8 females, sedation deepened to coma 4 - 40 h after application. Death occurred in coma, 12 - 24 h after application. Necropsy revealed pale parenchymal organs in animals found dead. Surviving animals showed no specific pathological findings.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
